Fairness opinions › Acquirers
Medtronic: healthcare acquisitions with fairness opinions
4 public-company targets, 2010-2022, $58B combined enterprise value. The multiples Medtronic paid and the banker analyses behind each target board's recommendation.
Deals
4
Median EV / EBITDA paid
14.7x
Median EV / revenue paid
4.71x
| Announced | Target | Acquirer | Segment | EV | EV/EBITDA | EV/Rev | DCF rate | Fairness opinion |
|---|---|---|---|---|---|---|---|---|
| 2022-05-13 | Intersect ENT | Medtronic | Medical Devices and Supplies | $1.3B | — | 8.08x | 9.5%–10.5% | |
| 2016-06-27 | HeartWare International | Medtronic | Medical Devices and Supplies | $1.1B | — | 4.47x | 10.0%–11.0% | Perella Weinberg Partners |
| 2014-06-15 | Covidien | Medtronic | Medical Devices and Supplies | $56B | 17.5x | 4.94x | 8.0%–9.0% | Goldman Sachs, Perella Weinberg Partners |
| 2010-08-17 | Osteotech | Medtronic | Medical Devices and Supplies | $123M | 11.8x | 1.26x | 14.0%–19.0% | Deutsche Bank |